Literature DB >> 31211897

Bacillus licheniformis, a potential probiotic, inhibits obesity by modulating colonic microflora in C57BL/6J mice model.

G T Cao1, B Dai2, K L Wang2, Y Yan1, Y L Xu2, Y X Wang2, C M Yang2.   

Abstract

AIMS: This study evaluated the effects of a potential probiotic, Bacillus sp., on the growth, serum and hepatic triglyceride, histological features of liver tissues and colonic microflora in high-fat diet-induced obese mice. METHODS AND
RESULTS: Sixty male C57BL/6J mice were randomly divided into five groups: mice fed a low-fat diet (Cont), mice fed a high-fat diet (Hf), Hf and orally challenged with Bacillus subtilis (Bs), B. licheniformis (Bl) and a mixture of B. subtilis and B. licheniformis (Bls). Gavage feeding was provided at week 9 and the experiment was continued for 8 weeks. Treatment with B. licheniformis and a mixture of Bacillus sp. attenuated body weight gain at the end of study and enhanced glucose tolerance by sensitizing insulin action in the Hf-fed mice. Lower serum and hepatic triglyceride and epididymal fat weight were observed in Bl and Bls groups than that of Hf group. Lesser hepatic fat deposition was observed in the Bl and Bls groups than in the Hf group. High-throughput sequencing showed that Bacillus sp. supplementation dramatically changed the colonic bacterial community in obese mice.
CONCLUSIONS: Bacillus licheniformis reduced body weight and improved glucose tolerance, obesity and insulin resistance in Hf-fed mice by changing colonic microbiota composition. SIGNIFICANCE AND IMPACT OF THE STUDY: Orally administration of Bacillus licheniformis may reduce body weight and decrease fat deposition by modulating colonic bacterial community in Hf model.
© 2019 The Society for Applied Microbiology.

Entities:  

Keywords:  Bacillus sp.; colonic microflora community; mice; obesity

Mesh:

Substances:

Year:  2019        PMID: 31211897     DOI: 10.1111/jam.14352

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  7 in total

1.  Novel Bacillus ginsengihumi CMRO6 Inhibits Adipogenesis via p38MAPK/Erk44/42 and Stimulates Glucose Uptake in 3T3-L1 Pre-Adipocytes through Akt/AS160 Signaling.

Authors:  Kyung Dong Lee; Soundharrajan Ilavenil; Muthusamy Karnan; Chul-Ju Yang; Dahye Kim; Ki Choon Choi
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

2.  Bacillus licheniformis Zhengchangsheng® Inhibits Obesity by Regulating the AMP-Activated Protein Kinase Signaling Pathway.

Authors:  Xiaojie Lu; Yue Jing; Xiaofei Zhou; Naisheng Zhang; Jiandong Tai; Yongguo Cao
Journal:  Probiotics Antimicrob Proteins       Date:  2021-05-05       Impact factor: 4.609

3.  Administration of Exogenous Melatonin Improves the Diurnal Rhythms of the Gut Microbiota in Mice Fed a High-Fat Diet.

Authors:  Jie Yin; Yuying Li; Hui Han; Jie Ma; Gang Liu; Xin Wu; Xingguo Huang; Rejun Fang; Kenkichi Baba; Peng Bin; Guoqiang Zhu; Wenkai Ren; Bie Tan; Gianluca Tosini; Xi He; Tiejun Li; Yulong Yin
Journal:  mSystems       Date:  2020-05-19       Impact factor: 6.496

4.  Hemolysin BL from novel Bacillus toyonensis BV-17 induces antitumor activity both in vitro and in vivo.

Authors:  Jiajia Chen; Shoukui Hu; Dengbo Ji; Zhaoya Gao; Hanyang Wang; Yong Yang; Yongkang Chen; Jin Gu
Journal:  Gut Microbes       Date:  2020-07-03

Review 5.  Potential application of the probiotic Bacillus licheniformis as an adjuvant in the treatment of diseases in humans and animals: A systematic review.

Authors:  Hugo Ramirez-Olea; Bernardo Reyes-Ballesteros; Rocio Alejandra Chavez-Santoscoy
Journal:  Front Microbiol       Date:  2022-09-26       Impact factor: 6.064

6.  Representative Bacillus sp. AM1 from Gut Microbiota Harbor Versatile Molecular Pathways for Bisphenol A Biodegradation.

Authors:  Ana López-Moreno; Alfonso Torres-Sánchez; Inmaculada Acuña; Antonio Suárez; Margarita Aguilera
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

7.  Isolation and Characterization of a Deoxynivalenol-Degrading Bacterium Bacillus licheniformis YB9 with the Capability of Modulating Intestinal Microbial Flora of Mice.

Authors:  Shiwei Wang; Qiuqiu Hou; Qianqian Guo; Jian Zhang; Yanmei Sun; Hong Wei; Lixin Shen
Journal:  Toxins (Basel)       Date:  2020-03-15       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.